The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Podcasts
Dr. Cherf, Chief Medical Officer at Lumere, and Dr.
Webcast
AHRMM presents a four-part series on successful collaboration with suppliers.
Book
This book was written to enhance the strategic contributions of the healthcare supply chain in a way that is most meaningful to hospitals’ an
White Papers
AHRMM19 CQO Summit White Paper entitled CQO: The Power of Clinical Integration.
Webcast
Lana Makhanik and Peter Fiorentino discuss discus why Beth Israel Deaconess Medical Center is breathing easier after they overhauled their inventor
On-Demand Educational Webinars
New risk sharing models align the economics of an agreement to product or service performance and outcomes. In this webinar, we discuss this…